跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLEOLAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GLEOLAN
Authorized
STANDARD
GLEOLAN
medexus pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4cba3968bdd3bbd1
Company
medexus pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
4cba3968bdd3bbd1
Drug Approval Canada Name
GLEOLAN
Product Name
GLEOLAN
Status
Marketed
Status Date
2021-02-22
Original Market Date
2021-02-22
Din
02504928
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
36:68.00
Atc Original
L01XD04 AMINOLEVULINIC ACID
Atc Name
l 01 xd 04
Aig Number
0143983002
Company Name
medexus pharmaceuticals inc.
Company Address
35 Nixon Road, Unit 10, Bolton, Ontario, Canada, L7E 1K1
Active Ingredients
AMINOLEVULINIC ACID HYDROCHLORIDE
1.5 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4cba3968bdd3bbd1
Type
Standard
Back to Health Canada Approvals